Study: Indian biotechs set to grow, but early funding is tight

04/9/2007 | AlertNet · Red Herring

A new study says India's biotech companies are poised to gain access to a larger portion of the world market for drugs and vaccines. However, the sector is having trouble finding investors willing to provide early-stage funding, and some biotechs are forced to jeopardize re-investing in R&D. A new financing model "is clearly needed to enable companies trying to develop innovative products to succeed," researchers said.

View Full Article in:

AlertNet · Red Herring

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park